ADAM17 and neoplasm: To confirm whether TMI-5-based ADAM17 inhibition may have a direct in vivo anti-angiogenic effect, independent of the presence of a tumor, we tested the ability of TMI-1 and TMI-5 to inhibit endothelial cell sprouting in the ex vivo aortic ring model.